What happens when clinical trials end?

Join Emily and Alex (CEO and founders of Duchenne UK) as they speak with Prof Volker Straub (Director of the John Walton Muscular Dystrophy Centre, Newcastle); Emma Hallam (Parent and CEO of Alex's Wish); and Matthew Anderton (Director of Clinical Operations, WAVE Life Sciences) about what happens when trials come to an end, either because of data from an earlier trial, or when they naturally complete.



We have placed cookies on your computer to help make this website better. For more information please click here

By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here